WNT2 and neuroblastoma: Investigations have illuminated that the constituents of the Wnt/β-catenin signaling pathway, including the activation of Wnt ligands such as WNT1, WNT2, and WNT5A, and the maladjustment of β-catenin, a pivotal downstream effector, contribute to NB progression [19].